FGF19 and metabolic disease: Accumulating evidence suggests that multiple circulating cytokines are correlated with lipid and glucose metabolism.[12,17,18] Furthermore, several independent groups have found that FGF19, as a newly emerging metabolic regulator, was highly likely associated with multiple metabolic disorders.